Advancing Access to Cell and Gene Therapies in Medicaid
JAMA · 2024
DOI: 10.1001/jama.2024.6224 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, 2024. Verfasst von Joseph T Kannarkat und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Maryland, Baltimore. Hauptthemen laut MEDLINE: Cell- and Tissue-Based Therapy, Genetic Therapy, Health Services Accessibility, Medicaid. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 7 Literaturangaben.
Abstract (Originalsprache)
This Viewpoint presents the components of the payment model and the implementation challenges among the Center for Medicare and Medicaid Innovation, state Medicaid agencies, patients, and manufacturers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- School of Medicine, University of Maryland, Baltimore.
- Division of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, La Jolla.
- Marathon Health, Indianapolis, Indiana.
Zitieren
APA
Kannarkat, J. T., Hernandez, I., & Parekh, N. (2024). Advancing Access to Cell and Gene Therapies in Medicaid. JAMA. https://doi.org/10.1001/jama.2024.6224
Vancouver
Kannarkat JT, Hernandez I, Parekh N. Advancing Access to Cell and Gene Therapies in Medicaid. JAMA. 2024. doi:10.1001/jama.2024.6224
BibTeX
@article{Kannarkat2024,
author = {Kannarkat, Joseph T and Hernandez, Inmaculada and Parekh, Natasha},
title = {Advancing Access to Cell and Gene Therapies in Medicaid},
journal = {JAMA},
year = {2024},
doi = {10.1001/jama.2024.6224}
}
EUVIMED